MarketInOut Stock Screener Log In | Sign Up
 

NewcelX Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
NewcelX Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization15.36 mln
Float2.54 mln

EPS

0.52
Decent

P / E

5.12
Undervalued

Piotroski F-Score

3 / 9
Below average

Relative Strength

20 / 100
Significantly lagging

Debt / Equity

0.07
Debt-free

ROE

-65.00
Deeply negative

Business Description

NewcelX Ltd. was established in 2008 and operates out of Zurich, Switzerland. The company works to create new medical treatments targeting diseases that affect the brain and the body's ability to process energy. Its research focuses on two main approaches: using living cells and developing chemical compounds as potential therapies.

Key Fundamentals

EPS0.52
P/E5.12
ROE-65.00
ROIC-57.59
ROA-41.32
Interest Cover-1.21
EBITDA, mln-2.77
EV / EBITDA-6.48
EV / EBIT-6.43

Quote Details

Last 2.66
Change 0.1 (3.91%)
Open 2.53
Volume 10,292
Turnover 27,377
Average Volume 6,631.1

Financial Ratios

Leverage Ratio1.61
Current Ratio0.32
Price / Book2.75
Debt / Equity0.07

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio1.73

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.4% 91 / 100   
1 Month -7.96% 33 / 100   
2 Months -33% 15 / 100   
6 Months -42.92% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog